Post Content

Before drug manufacturers ship vaccines to distributors they, along with the Food and Drug Administration (FDA), always test them to determine that they meet all safety and efficacy standards. As part of its quality assurance program, manufacturer Sanofi Pasteur, performs additional routine, ongoing tests of their flu vaccines to ensure that they continue to meet required specifications after they have been distributed health care providers.

This week, after performing these tests, Sanofi Pasteur notified Centers for Disease Control (CDC) and the FDA that the antigen content in a batch (known as a "lot") of syringes intended for children 6 months through 35 months of age distributed to providers in November, had dropped below a pre-specified limit making them slightly less potent.

Consequently, Sanofi Pasteur tested additional lots and found that three others also had an antigen content that had fallen below pre-specified limits. This means that doses from these four vaccine lots no longer meet the specifications for antigen content. Therefore, Sanofi is conducting a voluntary recall of these affected lots and has asked providers to return any vaccine they may have from these lots to the manufacturer.

The affected vaccine met all specifications at the time of release and both CDC and FDA have determined that there are no safety concerns for children who received this vaccine. Parents of children who received vaccines from the recalled lots do not need to take any action other than make sure their child receives their second dose if they have not already. There is NO need to revaccinate children who have received vaccine from these lots. The antigen content in the affected lots of vaccine is only slightly below the specification limit and experts expect it to still be effective against the H1N1 flu.

This drop in antigen content below the required specification only occurred in Sanofi Pasteur’s pediatric H1N1 monovalent vaccine in 0.25 mL pre-filled syringes. The same vaccine packaged in other forms, such as pre-filled syringes for older children and adults and multi-dose vials, continue to meet specifications.

For additional information please see CDC’s Questions and Answers related to the withdrawn vaccine at http://www.cdc.gov/h1n1flu/vaccination/syringes_qa.htm

We encourage all residents to utilize the comments section on this blog to engage with us and each other. While we cannot respond to every comment or question directly, we find them very helpful to understand your questions and concerns and plan for future posts.

Written By:


Communications Office

Recent Posts

Weekly Flu Report, November 21, 2014 posted on Nov 21

This week’s flu report indicates that rates of flu-like illness remained relatively stable as compared to last week’s numbers. It’s safe to say that we’ll see these rates rise in the coming weeks and months – and with the holiday season approaching, now’s a great time   …Continue Reading Weekly Flu Report, November 21, 2014

The Holidays Are Fast Approaching! posted on Nov 18

The Holidays Are Fast Approaching!

The holiday season brings a lot of fun, but can be stressful at times. Try focusing on seeing things through your child’s eyes. Chances are the traditions and memories you make are what children will grow up to remember, not the gifts or fancy meals.   …Continue Reading The Holidays Are Fast Approaching!

Weekly Flu Report, November 14, 2014 posted on Nov 17

The latest weekly flu report shows an increase in the rate of flu-like illness in Massachusetts over the past seven days. This is to be expected at this time of year in New England, and it’s a great reminder that if you haven’t gotten vaccinated yet, there   …Continue Reading Weekly Flu Report, November 14, 2014